Luis Arias, MD; and Paolo Lanzetta, MD, recently found themselves on opposite sides of the debate table regarding the value ...

While anti-VEGF therapies remain the current standard of care, many DME patients experience suboptimal responses due to ...

DAVIO-2 for wet AMD and VERONA for DME. In the DAVIO-2 trial, patients previously treated with approximately 10 injections in ...

Group sales In the first nine months of 2025, Roche achieved sales growth of 7% (2% in CHF) to CHF 45.9 billion due to strong demand for our pharmaceutical and diagnostic products.

Of the 38 patients with age-related macular degeneration, 80% were able to read again after having the eye implant and using ...

The treatment involves inserting a tiny implant thinner than human hair under the retina. Patients then have to wear glasses ...

The tiny blood vessels in your eyes might hold the key to predicting a person's risk of developing heart disease and how fast ...

Today, in the New England Journal of Medicin e, researchers announced that they restored some vision to elderly patients with ...

A small wireless chip and a pair of smart glasses are offering new hope to people who thought they’d never read again. The ...

The device helped people with an advanced form of age-related macular degeneration, which affects about 1 million people in ...

A groundbreaking European trial has shown that a new electronic eye implant, paired with augmented-reality glasses, can restore reading vision to patients blinded by geographic atrophy from dry ...

UB ophthalmologist Margaret DeAngelis leads work on the neurological condition that's the leading cause of blindness in adults over 55.